Newspoint on MSN

RCB's win, Messi's 'Jai Mata Di' and more Internet moments 2025

Hyderabad: If someone had claimed in 2024 that 2025 would look like fan fiction coming alive, most would’ve laughed it off.

Third Time's The Charm: Outlook Therapeutics' Lytenava Heads To FDA, Again

Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...